- Home
- CCO vs RLAY Comparison
CCO vs RLAY Comparison
Compare CCO & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCO
- RLAY
- Stock Information
- Founded
- CCO 1995
- RLAY 2015
- Country
- CCO United States
- RLAY United States
- Employees
- CCO N/A
- RLAY N/A
- Industry
- CCO Advertising
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CCO Consumer Discretionary
- RLAY Health Care
- Exchange
- CCO Nasdaq
- RLAY Nasdaq
- Market Cap
- CCO 586.1M
- RLAY 490.3M
- IPO Year
- CCO 2005
- RLAY 2020
- Fundamental
- Price
- CCO $1.12
- RLAY $3.18
- Analyst Decision
- CCO Buy
- RLAY Strong Buy
- Analyst Count
- CCO 4
- RLAY 11
- Target Price
- CCO $1.88
- RLAY $18.40
- AVG Volume (30 Days)
- CCO 2.0M
- RLAY 1.5M
- Earning Date
- CCO 08-06-2025
- RLAY 08-05-2025
- Dividend Yield
- CCO N/A
- RLAY N/A
- EPS Growth
- CCO N/A
- RLAY N/A
- EPS
- CCO N/A
- RLAY N/A
- Revenue
- CCO $1,512,570,000.00
- RLAY $7,679,000.00
- Revenue This Year
- CCO $5.10
- RLAY $14.31
- Revenue Next Year
- CCO $3.29
- RLAY N/A
- P/E Ratio
- CCO N/A
- RLAY N/A
- Revenue Growth
- CCO 14.28
- RLAY N/A
- 52 Week Low
- CCO $0.81
- RLAY $1.78
- 52 Week High
- CCO $1.88
- RLAY $10.72
- Technical
- Relative Strength Index (RSI)
- CCO 51.16
- RLAY 55.48
- Support Level
- CCO $1.08
- RLAY $2.98
- Resistance Level
- CCO $1.17
- RLAY $3.48
- Average True Range (ATR)
- CCO 0.05
- RLAY 0.25
- MACD
- CCO -0.00
- RLAY -0.00
- Stochastic Oscillator
- CCO 56.25
- RLAY 58.45
About CCO Clear Channel Outdoor Holdings Inc.
Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).